阿片类镇痛药物的研究进展
Research Progress of Opioid Analgesics
摘要: 阿片类药物是目前应用最广泛的镇痛药，对于中度至重度剧烈疼痛的治疗仍不可替代。阿片类镇痛药是一种作用于中枢神经系统能解除或减轻疼痛并改变对疼痛的情绪反应的药物。医学界的研究中，阿片类镇痛药物一直是研究的热点并已取得了良好的进展。本文根据目前传统阿片类镇痛药物，对新型阿片类镇痛药物以及复方阿片类镇痛药物有关实验研究进行综述，为其临床应用提供理论依据。
Abstract: Opioids are irreplaceable for the treatment of moderate to severe pain and currently the most widely used analgesics. Opioid are drugs that act on the central nervous system to relieve or reduce pain and alter the emotional response to pain. In the medical research field, opioid analgesics have always been a hot research topic and made good progress. Based on the existing traditional opioid analgesics, this article provides an overview of the novel opioid analgesics and compound opioid analgesics and theoretical basis for their clinical application.
文章引用：姚李欣, 丁怡帆, 王佳淇, 朱海丽, 王柏军. 阿片类镇痛药物的研究进展[J]. 药物资讯, 2024, 13(3): 162-168. https://doi.org/10.12677/pi.2024.133020

参考文献

[1] 宋学军, 樊碧发, 万有, 等. 国际疼痛学会新版疼痛定义修订简析[J]. 中国疼痛医学杂志, 2020, 26(9): 641-644.
[2] Mercadante, S., Arcuri, E. and Santoni, A. (2019) Opioid-Induced Tolerance and Hyperalgesia. CNS Drugs, 33, 943-955. [Google Scholar] [CrossRef] [PubMed]
[3] 白毅. 阿片类药物产生耐受性新机制被揭示[N]. 中国医药报, 2014-07-15(006).
[4] Jin, D., Chen, H., Zhou, M.H., et al. (2023) MGluR5 from Primary Sensory Neurons Promotes Opioid-Induced Hyperalgesia and Tolerance by Interacting with and Potentiating Synaptic NMDA Receptors. Journal of Neuroscience, 43, 5593-5607. [Google Scholar] [CrossRef] 
[5] Mas-Orea, X., Basso, L., Blanpied, C., et al. (2022) Delta Opioid Receptors on Nociceptive Sensory Neurons Mediate Peripheral Endogenous Analgesia in Colitis. Journal of Neuroinflammation, 19, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
[6] Wicks, C., Hudlicky, T. and Rinner, U. (2021) Morphine Alkaloids: History, Biology, and Synthesis. The Alkaloids: Chemistry and Biology, 86, 145-342. [Google Scholar] [CrossRef] [PubMed]
[7] Le Guen, S., Gestreau, C. and Besson, J.M. (2003) Morphine Withdrawal Precipitated by Specific Mu, Delta or Kappa Opioid Receptor Antagonists: A C-Fos Protein Study in the Rat Central Nervous System. European Journal of Neuroscience, 17, 2425-2437. [Google Scholar] [CrossRef] [PubMed]
[8] Xu, J., Bian, X., Zhao, H., et al. (2022) Morphine Prevents Ischemia/Reperfusion-Induced Myocardial Mitochondrial Damage by Activating δ-Opioid Receptor/EGFR/ROS Pathway. Cardiovascular Drugs and Therapy, 36, 841-857. [Google Scholar] [CrossRef] [PubMed]
[9] Terminel, M.N., Bassil, C., Rau, J., et al. (2022) Morphine-Induced Changes in the Function of Microglia and Macrophages after Acute Spinal Cord Injury. BMC Neuroscience, 23, Article No. 58. [Google Scholar] [CrossRef] [PubMed]
[10] Onay, M., ŞanalBaş, S., Işıker, A., et al. (2023) Effect of Intrathecal Morphine on Postdural Puncture Headache in Obstetric Anaesthesia. Turkish Journal of Anaesthesiology and Reanimation, 51, 297-303. [Google Scholar] [CrossRef] 
[11] Grond, S. and Sablotzki, A. (2004) Clinical Pharmacology of Tramadol. Clinical Pharmacokinetics, 43, 879-923. [Google Scholar] [CrossRef] [PubMed]
[12] Ossipov, M.H., Dussor, G.O. and Porreca, F. (2010) Central Modulation of Pain. Journal of Clinical Investigation, 120, 3779-3787. [Google Scholar] [CrossRef] 
[13] Fields, H.L., Barbaro, N.M. and Heinricher, M.M. (1988) Brain Stem Neuronal Circuitry Underlying the Antinociceptive Action of Opiates. Progress in Brain Research, 77, 245-257. [Google Scholar] [CrossRef] 
[14] Ganti, S., Shriram, P., Ansari, A.S., et al. (2018) Evaluation of Effect of Glucosamine-Chondroitin Sulfate, Tramadol, and Sodium Hyaluronic Acid on Expression of Cytokine Levels in Internal Derangement of Temporomandibular Joint. The Journal of Contemporary Dental Practice, 19, 1501-1505. [Google Scholar] [CrossRef] 
[15] Subedi, M., Bajaj, S., Kumar, M.S., et al. (2019) An Overview of Tramadol and Its Usage in Pain Management and Future Perspective. Biomedicine & Pharmacotherapy, 111, 443-451. [Google Scholar] [CrossRef] [PubMed]
[16] Yekkirala, A.S., Roberson, D.P., Bean, B.P. and Woolf, C.J. (2017) Breaking Barriers to Novel Analgesic Drug Development. Nature Reviews Drug Discovery, 16, 545-564. [Google Scholar] [CrossRef] [PubMed]
[17] Zou, S., Sun, H., Peng, Y., et al. (2023) Mu-Opioid Receptor Alleviated Ferroptosis in Hepatic Ischemia-Reperfusion Injury via the HIF-1α/KCNQ1OT1 Axis. American Journal of Physiology-Cell Physiology, 324, C927-C940. [Google Scholar] [CrossRef] [PubMed]
[18] Serra, P.A., Susini, G., Rocchitta, G., et al. (2003) Effects of Sufentanil on the Release and Metabolism of Dopamine and Ascorbic Acid and Glutamate Release in the Striatum of Freely Moving Rats. Neuroscience Letters, 344, 9-12. [Google Scholar] [CrossRef] 
[19] Lu, Y., Piao, Z., Li, J., et al. (2022) Sufentanil Promotes Autophagy and Improves Ischemia-Reperfusion-Induced Acute Kidney Injury via Up-Regulating MicroRNA-145. Journal of Central South University, 47, 1315-1323.
[20] Hu, Q., Wang, Q., Han, C. and Yang, Y. (2020) Sufentanil Attenuates Inflammation and Oxidative Stress in Sepsis-Induced Acute Lung Injury by Downregulating KNG1 Expression. Molecular Medicine Report, 22, 4298-4306. [Google Scholar] [CrossRef] [PubMed]
[21] Li, M., Gu, K., Kong, Q., et al. (2023) Sufentanil Inhibits the Metastasis and Immune Response of Breast Cancer via Mediating the NF-κB Pathway. Immunopharmacology and Immunotoxicology, 45, 663-671. [Google Scholar] [CrossRef] [PubMed]
[22] Zhu, W. and Pan, Z.Z. (2005) Mu-Opioid-Mediated Inhibition of Glutamate Synaptic Transmission in Rat Central Amygdala Neurons. Neuroscience, 133, 97-103. [Google Scholar] [CrossRef] [PubMed]
[23] Llorca-Torralba, M., Borges, G., Neto, F., et al. (2016) Noradrenergic Locus Coeruleus Pathways in Pain Modulation. Neuroscience, 338, 93-113. [Google Scholar] [CrossRef] [PubMed]
[24] Chang, E.J., Choi, E.J. and Kim, K.H. (2016) Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows? The Korean Journal of Pain, 29, 153-157. [Google Scholar] [CrossRef] [PubMed]
[25] Obata, H. (2017) Analgesic Mechanisms of Antidepressants for Neuropathic Pain. International Journal of Molecular Sciences, 18, Article 2483. [Google Scholar] [CrossRef] [PubMed]
[26] Raffa, R.B., Buschmann, H., Christoph, T., et al. (2012) Mechanistic and Functional Differentiation of Tapentadol and Tramadol. Expert Opinion on Pharmacotherapy, 13, 1437-1449. [Google Scholar] [CrossRef] [PubMed]
[27] Lockwood, S.M. and Dickenson, A.H. (2019) A Combination Pharmacotherapy of Tapentadol and Pregabalin to Tackle Centrally Driven Osteoarthritis Pain. European Journal of Pain, 23, 1185-1195. [Google Scholar] [CrossRef] [PubMed]
[28] Alavi, S.M., Ghoreishi, S.M., Chitsazan, M., et al. (2013) Patient-Controlled Analgesia after Coronary Bypass: Remifentanil or Sufentanil? Asian Cardiovascular and Thoracic Annals, 22, 694-699. [Google Scholar] [CrossRef] [PubMed]
[29] Li, H., Li, H., Yu, Y. and Lu, Y. (2023) Clinical Study on the Effect of Remifentanil Patient-Controlled Intravenous Labor Analgesia Compared to Patient-Controlled Epidural Labor Analgesia. Ginekologia Polska, 94, 544-551. [Google Scholar] [CrossRef] 
[30] Inagi, T., Suzuki, M., Osumi, M. and Bito, H. (2014) Remifentanil-Based Anaesthesia Increases the Incidence of Postoperative Surgical Site Infection. Journal of Hospital Infection, 89, 61-68. [Google Scholar] [CrossRef] [PubMed]
[31] 赵文菊. 用阿片类镇痛药对老年恶性肿瘤伴癌痛患者进行镇痛治疗的效果及安全性分析[J]. 当代医药论丛, 2019, 17(1): 26-27.
[32] Leppert, W. (2010) Role of Oxycodone and Oxycodone/Naloxone in Cancer Pain Management. Pharmacological Reports, 62, 578-591. [Google Scholar] [CrossRef] 
[33] Atti, A., Sabato, E., Di Paolo, A.R., Mammucari, M. and Sabato, A.F. (2010) Oxycodone/Paracetamol: A Low-Dose Synergic Combination Useful in Different Types of Pain. Clinical Drug Investigation, 30, 3-14. [Google Scholar] [CrossRef] 
[34] Friedman, B.W., Irizarry, E., Feliciano, C., et al. (2021) A Randomized Controlled Trial of Oxycodone/Acetaminophen versus Acetaminophen Alone for Emergency Department Patients with Musculoskeletal Pain Refractory to Ibuprofen. Academic Emergency Medicine, 28, 859-865. [Google Scholar] [CrossRef] [PubMed]
[35] Gong, L., Stamer, U.M., Tzvetkov, M.V., Altman, R.B. and Klein, T.E. (2014) PharmGKB Summary: Tramadol Pathway. Pharmacogenetics and Genomics, 24, 374-380. [Google Scholar] [CrossRef] 
[36] Xiang, C., Pan, M., Shen, Q., et al. (2021) Clinical Consumption of Compound Opioid Analgesics in China: A Retrospective Analysis of National Data 2015-2018. Biological and Pharmaceutical Bulletin, 44, 1316-1322. [Google Scholar] [CrossRef] [PubMed]
[37] Yoshizawa, K., Arai, N., Suzuki, Y., et al. (2020) Synergistic Antinociceptive Activity of Tramadol/Acetaminophen Combination Mediated by μ-Opioid Receptors. Biological and Pharmaceutical Bulletin, 43, 1128-1134. [Google Scholar] [CrossRef] [PubMed]